Ardana Bioscience Ltd.
๐ฌ๐งUnited Kingdom
- Country
- ๐ฌ๐งUnited Kingdom
- Ownership
- Private
- Established
- 2000-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.ardana.co.uk
Study of 3 Doses of ARD-0403 in Testosterone Deficient Men
Phase 2
Completed
- Conditions
- Hypogonadism
- First Posted Date
- 2008-01-17
- Last Posted Date
- 2008-01-17
- Lead Sponsor
- Ardana Bioscience Ltd
- Target Recruit Count
- 42
- Registration Number
- NCT00597051
- Locations
- ๐ง๐พ
Republican Endocrinology Center Hospital, Minsk, Belarus
Open-Label Study of ARD-0403 in Testosterone Deficient Men
Phase 3
Terminated
- Conditions
- Hypogonadism
- First Posted Date
- 2007-11-22
- Last Posted Date
- 2008-04-01
- Lead Sponsor
- Ardana Bioscience Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT00562731
- Locations
- ๐บ๐ธ
Johns Hopkins University, Baltimore, Maryland, United States
๐บ๐ธMassachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธBaylor College of Medicine, Houston, Texas, United States
Open-Label Study of ARD-0403 in Testosterone Deficient Men
Phase 3
Completed
- Conditions
- Hypogonadism
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2008-04-18
- Lead Sponsor
- Ardana Bioscience Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT00448955
- Locations
- ๐บ๐ธ
Oregon Health and Science University, Portland, Oregon, United States
๐บ๐ธMedical Affiliated Research Center, Inc, Huntsville, Alabama, United States
๐บ๐ธDuke University Medical Center, Durham, North Carolina, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath